Robert Douglas Bruce MD, MA, MSc

Associate Clinical Professor of Medicine (Infectious Diseases)

Departments & Organizations

Yale Medical Group

Program for Biomedical EthicsHIV/AIDSInfectious DiseasesSchool of Public Health: Heimer Lab - HIVInternal Medicine: Viral Hepatitis Program; Addiction Medicine; Infectious Diseases: AIDS Care Program

Research Interests

Substance abuse/dependence; Infectious diseases; HIV; Hepatitis C more...


  • BS, Houston Baptist University, 1993
  • M.D., University of Texas at Dallas, 1997
  • M.A., Yale Divinity School, 2003
  • M.Sc., Yale University School of Public Health, 2008

Selected Publications

  • Bruce RD, Eiserman J, Acosta A, Gote C, Lim JK, Altice FL. Developing a Modified Directly Observed Therapy Intervention for Hepatitis C Treatment in a Methadone Maintenance Program: Implications for Program Replication. American Journal of Drug and Alcohol Abuse. 2012 May; 38(3):206-12.
  • Bruce RD, Moody DE, Wenfang BF, Chodkowski D, Andrews L, Friedland GH. Tipranavir/Ritonavir Induction of Buprenorphine Glucuronide Metabolism in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone. American Journal of Drug and Alcohol Abuse. 2011 Jul; 37(4):224-8.
  • Bruce RD, Altice FL, Moody DE, Morse GD, Andrews L, Lin S, Fang WB, Ma Q, Friedland GH. Pharmacokinetic Interactions between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir. JAIDS. 2010 Aug: 54(5):511-4. NIHMS 198833



Latest News


Edit Profile